Diabetes Research and Clinical Practice
Volume 61, Issue 2 , Pages 81-88 , August 2003

Relationship between carotid atherosclerosis and erythrocyte membrane cholesterol oxidation products in type 2 diabetic patients

Received 29 November 2002 ,Revised 7 March 2003 ,Accepted 10 April 2003.

References 

  1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J. Med. 1993;329:977–986
  2. Ohkubo Y, Kishikawa H, Araki E, et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 1995;28:103–117
  3. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  4. Donahue RP, Abbott RD, Reed DM, Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes. 1987;36:689–692
  5. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48:1–9
  6. Kashiwagi A, Shinozaki K, Nishio Y, Okamura T, Toda N, Nikkawa R. Free radical production in endothelial cells as a pathogenetic factor for vascular dysfunction in the insulin resistance state. Diabetes Res. Clin. Pract. 1999;45:199–203
  7. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 1998;50:21–33
  8. Asahina T, Kashiwagi A, Nishio Y, et al.  Impaired activation of glucose oxidation and NADPH supply in human endothelial cells exposed to H2O2 in high-glucose medium. Diabetes. 1995;44:520–526
  9. Young IS, Tate S, Lightbody JH, McMaster D, Trimble ER. The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic. Biol. Med. 1995;18:833–840
  10. Inouye M, Mio T, Sumino K. Glycated hemoglobin and lipid peroxidation in erythrocyte of diabetic patients. Metabolism. 1999;48:205–209
  11. Kawamori R, Yamasaki Y, Matsushima H, et al.  Prevalence of carotid atherosclerosis in diabetic patients, ultrasound high-resolutional B-mode imaging on carotid arteries. Diabetes Care. 1992;15:1290–1294
  12. Yamasaki Y, Kawamori R, Matsushima H, et al.  Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes. 1994;43:634–639
  13. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation. 1998;97:135–137
  14. Rigat B, Hubert C, Gelas FA, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 1990;86:1343–1346
  15. Cambien F, Poirier O, Lecerf L, et al.  Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641–644
  16. Honda Y, Honda S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J. 1999;13:1385–1393
  17. Kopp CB, Touboul PJ, Berr C, et al.  Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler. Thromb. Vasc. Biol. 1996;16:310–316
  18. Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler. Thromb. 1994;14:1098–1104
  19. Vasankari T, Ahotupa M, Toikka J, et al.  Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy. Atherosclerosis. 2001;155:403–412
  20. Wofford JL, Kahl FR, Howard GR, McKinney WM, Toole JF, Crouse JR. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler. Thromb. 1991;11:1786–1794
  21. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. New Engl. J. Med. 1999;340:14–22
  22. Chambless LE, Heiss G, Folsom AR, et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors. The Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am. J. Epidemiol. 1997;146:483–494
  23. Giugliano D, Paolisso G, Ceriello A. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19:257–267
  24. Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation. 1997;95:1062–1071
  25. Stratton IM, Adler AI, Neil HA, et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br. Med. J. 2000;321:405–412
  26. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Diabetes. 1999;48:383–390
  27. Holvoet P, Vanhaecke J, Janssens S, Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998;98:1487–1494

PII: S0168-8227(03)00108-6

doi: 10.1016/S0168-8227(03)00108-6

Diabetes Research and Clinical Practice
Volume 61, Issue 2 , Pages 81-88 , August 2003